Core Viewpoint - Double Tower Food, the world's largest pea protein producer, is facing significant performance decline, with a projected net profit of 28 million to 40 million yuan for 2025, representing a year-on-year decrease of 70.41% to 57.72% [1] Group 1: Financial Performance - The company reported an asset impairment loss of 68.9884 million yuan in the first three quarters of 2025, an increase of 40.42% compared to the beginning of the period, primarily due to increased inventory of starch and higher provisions for inventory depreciation [1] - In 2021 and 2022, the company's net profit was 268 million yuan and -311 million yuan, reflecting year-on-year declines of 24.12% and 216% respectively [2] - The company experienced a recovery in 2023, with net profits of 93 million yuan and 95 million yuan for 2023 and 2024, showing year-on-year growth of 130% and 1.48% respectively [2] Group 2: Market Challenges - The decline in performance is attributed to external trade friction and internal price cycles, with high raw material costs and falling prices in the pea starch market leading to increased inventory impairment provisions [3] - The European Union initiated an anti-dumping investigation against Chinese pea protein on September 1, 2025, affecting products with protein content over 65%, which could impact the company's export sales [1] Group 3: Strategic Initiatives - The company is actively expanding into emerging international markets and enhancing domestic market development, with domestic sales revenue increasing by 15.63% year-on-year in the first half of 2025 [3] - The company has established a factory in Thailand, which has commenced production, indicating efforts to strengthen its international presence [3] - Experts suggest that the company has core competitive advantages in the domestic plant protein market but faces challenges from intense competition and a relatively weak brand influence [3]

Core Viewpoint - Double Tower Food, the world's largest pea protein producer, is facing significant pressure on its performance, with a projected net profit decline of 70.41% to 57.72% for 2025 compared to the previous year due to challenges in overseas exports and a decrease in pea starch prices leading to asset impairment [1][3]. Financial Performance - The company anticipates a net profit of 28 million to 40 million yuan for 2025, reflecting a substantial decline [1]. - For the first three quarters of 2025, asset impairment losses reached -68.99 million yuan, an increase of 40.42% from the beginning of the period, attributed to rising starch inventory and increased provisions for inventory depreciation [3]. - In 2021 and 2022, the company's net profits were 268 million yuan and -311 million yuan, respectively, showing a year-on-year decline of 24.12% and 216% [4]. - In contrast, the company saw a recovery in 2023 and 2024, with net profits of 93 million yuan and 95 million yuan, representing year-on-year growth of 130% and 1.48% [4]. Market Challenges - The European Union initiated an anti-dumping investigation against Chinese pea protein on September 1, 2025, affecting products with protein content exceeding 65% on a dry weight basis, with the sales of affected products accounting for 3.92% of total revenue in 2024 and increasing to 6.48% in the first half of 2025 [3]. - The company is experiencing dual pressures from external trade friction and internal price cycles, which have highlighted its limited bargaining power in the supply chain and the vulnerability of its business structure [4]. Strategic Initiatives - The company is actively expanding into emerging international markets and enhancing its domestic market presence, with domestic sales revenue increasing by 15.63% year-on-year in the first half of 2025, raising its revenue share to 53.89% [4]. - The Thai factory has been completed and is now operational, contributing to the company's international expansion efforts [4]. Competitive Positioning - As a leader in the pea protein market, the company possesses scale production capacity and mature production technology, providing a competitive edge [5]. - However, the domestic market faces intense competition, and the company's previous focus on B2B rather than B2C has resulted in relatively weak brand influence and a limited product matrix [5]. - There is potential for the company to leverage its production advantages to penetrate the domestic plant-based milk and meat markets while enhancing brand development and product innovation [5].

Group 1 - The core point of the article is that Shuangta Food has announced that its controlling shareholder, Junxing Agriculture, has pledged 4 million shares, which raises concerns about the financial stability of the company [1] - As of the announcement date, Junxing Agriculture has pledged a total of approximately 247 million shares, representing 61.22% of its total holdings [1] Group 2 - The article also mentions the bankruptcy and liquidation of Baolide, a major automotive sales company known for selling luxury cars like Rolls-Royce and Porsche, indicating a significant shift in the automotive sales industry [1] - The headquarters in Hangzhou has been vacated, and the subsidiary in Yiwu has been sealed, highlighting the operational challenges faced by the company [1]

烟台双塔食品股份有限公司 证券代码：002481 证券简称：双塔食品 编号：2026-002 烟台双塔食品股份有限公司 烟台双塔食品股份有限公司 | 招远 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 市金 岭金 | 926,609 | 0.08% | -- | -- | -- | -- | -- | -- | 926,609 | 100% | | 矿 | | | | | | | | | | | | 合计 | 404,176, | 32.76 | 242,880 | 246,880 | 61.08% | 19.69% | 0 | 0.0% | 926,609 | 0.59% | | | 746 | % | ,000 | ,000 | | | | | | | 1、公司控股股东及其一致行动人本次质押与上市公司生产经营需求无关。 关于控股股东部分股份进行质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 烟台双塔食品股份有 ...

Core Viewpoint - Double Tower Food (002481.SZ) forecasts a significant decline in net profit for the fiscal year 2025, with expected earnings between 28 million to 40 million yuan, representing a year-on-year decrease of 57.72% to 70.41% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 28 million to 40 million yuan, a decline of 57.72% to 70.41% year-on-year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 25 million to 37 million yuan, reflecting a decrease of 55.61% to 70.01% year-on-year [1] - Basic earnings per share are estimated to be between 0.022 yuan to 0.032 yuan [1] Business Challenges - The overseas export business of pea protein has been significantly impacted [1] - The decline in the selling price of pea starch has led to asset impairment provisions [1]

Core Viewpoint - Double Tower Foods (002481.SZ) forecasts a significant decline in net profit for the fiscal year 2025, with expected earnings between 28 million to 40 million yuan, representing a year-on-year decrease of 57.72% to 70.41% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 28 million to 40 million yuan, a decline of 57.72% to 70.41% year-on-year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 25 million to 37 million yuan, reflecting a decrease of 55.61% to 70.01% year-on-year [1] - Basic earnings per share are estimated to be between 0.022 yuan to 0.032 yuan [1] Business Challenges - The overseas export business of pea protein has been significantly impacted, contributing to the decline in profitability [1] - The decrease in the selling price of pea starch has led to asset impairment provisions, further affecting financial results [1]

Core Viewpoint - ST Xiangxue expects a net profit loss of 635 million to 934 million yuan for the year 2025, primarily due to intensified market competition, liquidity crisis, high financial costs, and asset impairment [1] Group 1: Financial Performance - The company anticipates a significant loss in net profit for 2025, ranging from 635 million to 934 million yuan [1] - Factors affecting performance include increased market competition, liquidity issues, high financial expenses, and asset impairment [1] Group 2: Business Operations - Despite short-term operational challenges, the overall business situation remains normal, and the company aims to enhance profitability for sustainable operations [1] - The company has made significant progress in innovative drug research and development [1] Group 3: R&D Achievements - The company's subsidiary, Xiangxue Life Science Technology, has received clinical approval for the TCR-T cell therapy product "XLS-103 Injection" for treating advanced non-small cell lung cancer and advanced pancreatic cancer with specific genetic mutations [1] - This approval marks the sixth and seventh clinical trial permits obtained by Xiangxue Life Science based on its core TCR-T cell therapy technology and R&D platform [1] - The company has established a comprehensive platform covering antigen peptide discovery, TCR affinity optimization, and full-process development, with three TCR-T products targeting various solid tumors [1]

Group 1 - The core viewpoint of the article is that Shuangta Food has announced a profit forecast for 2025, expecting a significant decline in net profit compared to the previous year [1] - The company anticipates a net profit attributable to shareholders of between 28 million to 40 million yuan, representing a decrease of 57.72% to 70.41% year-on-year [1] - The basic earnings per share are projected to be between 0.022 yuan and 0.032 yuan [1]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要提示： 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于同向下降 50%以上情形 （1）以区间数进行业绩预告的 证券代码：002481 证券简称：双塔食品 公告编号：2026-001 烟台双塔食品股份有限公司 2025 年度业绩预告 公司本次业绩预告相关财务数据未经会计师事务所审计，但公司已就业绩预告有关事项与会计师事务所 进行了预沟通，公司与会计师事务所在业绩预告方面不存在重大分歧。 三、业绩变动原因说明 报告期内，一是公司豌豆蛋白海外出口业务受到较大影响；二是豌豆淀粉售价下降计提资产减值所致。 四、风险提示 本次业绩预告是公司财务部门初步测算的结果，未经审计机构审计。公司 2025 年度的具体财务数据 以 2025 年度报告披露的数据为准。敬请广大投资者谨慎决策，注意投资风险。 特此公告。 烟台双塔食品股份有限公司 单位：万元 | 项 目 | | | 本报告期 | | 上年同期 | | --- | --- ...

Core Viewpoint - The agricultural processing sector experienced a rise of 1.95% on January 29, with Andeli leading the gains, while the overall market showed mixed results with the Shanghai Composite Index up by 0.16% and the Shenzhen Component Index down by 0.3% [1]. Group 1: Stock Performance - Andeli (605198) closed at 46.30, up by 3.81% with a trading volume of 32,700 shares and a transaction value of 149 million yuan [1]. - Jinlongyu (666000E) closed at 30.61, up by 3.48% with a trading volume of 251,100 shares and a transaction value of 758 million yuan [1]. - Yishimo (920273) closed at 34.05, up by 3.40% with a trading volume of 31,600 shares and a transaction value of 10.6 million yuan [1]. - Zhongliang Sugar Industry (600737) closed at 17.39, up by 3.14% with a trading volume of 538,500 shares and a transaction value of 930 million yuan [1]. - Tianye Co., Ltd. (920023) closed at 4.75, up by 3.04% with a trading volume of 167,500 shares and a transaction value of 7.82 million yuan [1]. Group 2: Capital Flow - The agricultural processing sector saw a net inflow of 124 million yuan from institutional investors, while retail investors experienced a net outflow of 198 million yuan [2]. - Major stocks like Guannong Co. (600251) had a net inflow of 43.80 million yuan from institutional investors, while it faced a net outflow of 54.80 million yuan from retail investors [3]. - Zhongliang Technology (000930) recorded a net inflow of 29.17 million yuan from institutional investors, with a net outflow of 34.88 million yuan from retail investors [3].